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One and the same active ingredient can be used in different
pharmaceutical applications to treat and cure diseases. Fur-
thermore, the active ingredient can be used also in cosmetic
formulations to care or aid the healing process.When applied
topically via creams or lotions, they are referred as
cosmeceuticals. In general, one aims to improve the
bioavailability through tailored formulations and careful se-
lection of components. An example is the use of latanoprost
in ophthalmology for lowering the intraocular pressure in glau-
coma patients with side effects including stimulated growth
of eyelashes. Does this open up the possibility of using
latanoprost for the local treatment for hair loss?
Latanoprost, when applied topically, shows a stimulating
effect on the growth of eyelashes [1] and could serve as an agent
against extensive hair loss. Hyaluronic acid is an active com-
ponent which is selectively used against early skin aging [2].
The objective of this work was to establish surfactant stabi-
lized cosmetic formulations and create galenicals based on
latanoprost and creams based on hyaluronic acid.
Tococpherol was incorporated into lecithin based lipo-
somes.Tocopherol served as a model substance for a lipophilic
pharmacologically active ingredient. Using standard methods,
such as thin-film hydration method, followed by and
ultrasound-assisted formation of liposomes [3], we created
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particles of the desired size range. Hyaluronic acid was incor-
porated into various cream bases and viscosities weremeasured
at varying temperatures. Latanoprost based foam prepara-
tions were established and investigated with regard to foam
stability.
Aside from liposomes, charged polymers that are able to
bind and/or “complex” a drug are suitable for improving drug
delivery systems as well as for the generation of new phar-
maceuticals and cosmeceuticals.
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Fig. 1 Figure left: Left upper panel: Artistic interpretation of a liposome-based drug carrier. Right upper panel: Tissue treated
with a polymer based immune-histological test. Tumor tissue is stained in brown color (specific staining) with a blue
counterstaining of the surrounding tissue (unspecific staining). Bottom panel: Phase contrast photograph of exponentially
growing carcinoma cells (HCT-116: size bar: 200 μm).This figure was previously published in ref. [3]. Figure right: Different
phospholipids used in liposome formulations.
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